13F HOLDINGS REPORT
Artia Global Partners LP
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001937964-25-000006
Total Value
$415.6M
Positions
37
Other Managers
0
Confidential Omitted
No
Holdings (37)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VERONA PHARMA PLC | 925050106 | 924,204 | $87.4M | 21.03% |
| 2 | INSMED INC | INSM | 752,712 | $75.8M | 18.23% |
| 3 | ARGENX SE | ARGX | 78,311 | $43.2M | 10.39% |
| 4 | SOLENO THERAPEUTICS INC | SLNO | 494,424 | $41.4M | 9.97% |
| 5 | ELI LILLY & CO | LLY | 30,700 | $23.9M | 5.76% |
| 6 | BOSTON SCIENTIFIC CORP | BSX | 155,200 | $16.7M | 4.01% |
| 7 | MERUS N V | N5749R100 | 296,750 | $15.6M | 3.76% |
| 8 | QUEST DIAGNOSTICS INC | DGX | 81,717 | $14.7M | 3.53% |
| 9 | ASTRAZENECA PLC | AZN | 190,752 | $13.3M | 3.21% |
| 10 | VERONA PHARMA PLC | 925050106 | 91,800 | $8.7M | 2.09% |
| 11 | SPDR SER TR | 78464A870 | 100,000 | $8.3M | 2.00% |
| 12 | TREVI THERAPEUTICS INC | TRVI | 1,311,840 | $7.2M | 1.73% |
| 13 | ALNYLAM PHARMACEUTICALS INC | ALNY | 20,970 | $6.8M | 1.65% |
| 14 | PROSHARES TR II | 74347W601 | 168,000 | $5.8M | 1.40% |
| 15 | REGENERON PHARMACEUTICALS | REGN | 10,671 | $5.6M | 1.35% |
| 16 | SCHOLAR ROCK HLDG CORP | SRRK | 126,285 | $4.5M | 1.08% |
| 17 | INSMED INC | INSM | 40,000 | $4.0M | 0.97% |
| 18 | REVOLUTION MEDICINES INC | RVMDW | 104,190 | $3.8M | 0.92% |
| 19 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 63,930 | $3.0M | 0.72% |
| 20 | EYEPOINT PHARMACEUTICALS INC | EYPT | 316,700 | $3.0M | 0.72% |
| 21 | ABBVIE INC | ABBV | 14,500 | $2.7M | 0.65% |
| 22 | VIKING THERAPEUTICS INC | VKTX | 96,479 | $2.6M | 0.62% |
| 23 | ASCENDIS PHARMA A/S | ASND | 12,240 | $2.1M | 0.51% |
| 24 | TG THERAPEUTICS INC | TGTX | 54,515 | $2.0M | 0.47% |
| 25 | VERTEX PHARMACEUTICALS INC | VRTX | 4,400 | $2.0M | 0.47% |
| 26 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 41,830 | $1.5M | 0.37% |
| 27 | UNITED THERAPEUTICS CORP DEL | UTHR | 5,000 | $1.4M | 0.35% |
| 28 | MEREO BIOPHARMA GROUP PLC | MREO | 475,361 | $1.3M | 0.31% |
| 29 | PROTAGONIST THERAPEUTICS INC | PTGX | 22,951 | $1.3M | 0.31% |
| 30 | XENON PHARMACEUTICALS INC | XENE | 40,000 | $1.3M | 0.30% |
| 31 | BIOHAVEN LTD | BHVN | 80,000 | $1.1M | 0.27% |
| 32 | AVIDITY BIOSCIENCES INC | 05370A108 | 34,600 | $982,640 | 0.24% |
| 33 | KINIKSA PHARMACEUTICALS INTL | G52694109 | 29,200 | $807,964 | 0.19% |
| 34 | MINERALYS THERAPEUTICS INC | MLYS | 41,100 | $556,083 | 0.13% |
| 35 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 27,319 | $494,747 | 0.12% |
| 36 | JANUX THERAPEUTICS INC | JANX | 20,000 | $462,000 | 0.11% |
| 37 | TRAVERE THERAPEUTICS INC | TVTX | 30,900 | $457,320 | 0.11% |